Momenta Pharmaceuticals, Inc. http://www.alacrastore.com/company-snapshot/Momenta_Pharmaceuticals_Inc-2556975 Friday, July 25, 2008 6:30:58 PM 2556975 Momenta Pharmaceuticals, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1905346ccbn/T1905346norm...Good day and welcome to the Momenta Pharmaceuticals second quarter #### earnings call. Today's call is being recorded. At this time, I would like to turn the conference over to Miss Beverly Holley, Director of Investor Relations. Please go ahead, ma'am. ... 7/24/2008 5:06:56 PMMomenta106.0000FinalQ2 2008 Momenta Earnings Conference Call TranscriptMNTA10:00am ETTranscriptT1905346Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PZM-0001-26894641newstex/PZM-0001-26894641xml CAMBRIDGE, Mass., Jul. ##, #### (July delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Bruce A....0700000007014000070140120700300007003001130000001301000013010005130020001300200504000000040020000400200604016000040160270200000002002000020020067/24/2008 9:26:58 AM1800000018014000PrimeNewswirePZM-0001-26894641ALTUS PHARMACEUTICALS INC.ANTIGENICS INCMOMENTA PHARMACEUTICALS INCBruce LeicherCRAIG A WHEELERAGENALTUANTIMNTANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PZM-0001-26895477newstex/PZM-0001-26895477xml CAMBRIDGE, Mass., Jul. ##, #### (July delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced its financial...04000000040160000401601804016048040160010400200004002006070000000701400007014012070030000700300113000000130100001301000513002000130020057/24/2008 9:26:58 AM180000001800400018008000PrimeNewswirePZM-0001-26895477MOMENTA PHARMACEUTICALS INCCRAIG A WHEELERMNTANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PZM-0001-26766950newstex/PZM-0001-26766950xml CAMBRIDGE, Mass., Jul. ##, #### (July delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results...04000000040160000401601804016048070000000701400007014012070030000700300113000000130100001301000513002000130020057/18/2008 2:16:33 PM180000001800400018008000PrimeNewswirePZM-0001-26766950MOMENTA PHARMACEUTICALS INCMNTANewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1898759ccbn/T1898759norm...Good day, everyone, and welcome to the Momenta Pharmaceuticals call. Today's conference is being recorded. At this time, all participants are in a listen-only mode. There will be a question-and-answer session following the presentation. At this time, I would like to turn the conference over to Ms. Beverly Holley, Director of IR. Please go ahead, Ma'am. ... 7/11/2008 3:04:41 PMMomenta106.0000FinalMomenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone TranscriptMNTA8:30am ETTranscriptT1898759Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-26595725newstex/BW-0001-26595725xml Jul. ##, #### (Business Wire) -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today commented on Momenta Pharmaceuticals, Inc./Sandoz Inc.a€™s announcement regarding the filing of a Abbreviated New Drug Application (ANDA) containing...0700000007013000040000000400200004002006040160000401603107014000070140120700300007003001130000001301000013010005020000000200200002002008020020047/11/2008 11:16:40 AM1800000018020000180180001900000019001000Business WireBW-0001-26595725MOMENTA PHARMACEUTICALS INCTEVA PHARMACEUTICAL INDUSTRIES LTDMNTATEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PZM-0001-25908733newstex/PZM-0001-25908733xml CAMBRIDGE, Mass., Jun. ##, #### (June delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment...09000000090150000700000007014000070140120700300007003001040000000401600004016008040160010400200004002006040060000400600113000000130100001301000513002000130020056/11/2008 9:17:57 AM1800000018007000PrimeNewswirePZM-0001-25908733DONNELLEY R R & SONS COMEMORY PHARMACEUTICALS CORPMOMENTA PHARMACEUTICALS INCCRAIG A WHEELERJAMES R SULATMEMYMNTARRDNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1841541ccbn/T1841541norm...Good day, everyone, and welcome to the Momenta Pharmaceuticals First Quarter #### Earnings Call. (OPERATOR INSTRUCTIONS) At this time, I would like to turn the conference over to Ms. Beverly Holley, Director of IR. Please go ahead, ma'am. ... 5/7/2008 2:06:00 PMMomenta54.0000FinalQ1 2008 Momenta Earnings Conference Call TranscriptMNTA10:00am ETTranscriptT1841541Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PZM-0001-25076141newstex/PZM-0001-25076141xml CAMBRIDGE, Mass., May #, #### (PrimeNewswire delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial...0700000007013000040000000401600004016018040160010401600304002000040020060701400007014012070030000700300113000000130100001301000513002000130020055/7/2008 9:25:29 AM1800000018004000180120001900000019001000PrimeNewswirePZM-0001-25076141MOMENTA PHARMACEUTICALS INCCRAIG A WHEELERRam NULL SasisekharanMNTANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PZM-0001-24948875newstex/PZM-0001-24948875xml CAMBRIDGE, Mass., May #, #### (PrimeNewswire delivered by Newstex) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial...04000000040160000401604804016018070000000701400007014012070030000700300113000000130100001301000513002000130020055/1/2008 4:16:44 PM180000001800800018004000PrimeNewswirePZM-0001-24948875MOMENTA PHARMACEUTICALS INCMNTANewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1816692ccbn/T1816692norm... - Morgan Stanley - AnalystGood afternoon, and thanks for joining us. This is Sapna Srivastava from Morgan Stanley, Biotech Analyst. And joined by Craig Wheeler and Rick Shea from Momenta. Thanks for coming and thanks for all of you. Before I start, I just have to read this. Please note that all important disclosures, including [my personal] holding disclosures and Morgan Stanley disclosures appear in the Morgan Stanley public website at www.morganstanley.com. So with that, I think we want the session to be as interactive as possible, so please chime in for as many questions as you have. And maybe I'll just kick off with the first one. Clearly, you came -- Momenta -- following kind of an exciting ride for the last couple of years and you've seen the sentiment change a lot from your main catalyst, M-Enox. And if you could just give us a brief overview, where you are now, where you started, where you are now in your role as the CEO and focusing the firm. And then we have tons of other questions,... 5/1/2008 4:08:00 PMMomenta54.0000FinalMomenta at Morgan Stanley 2008 Global Healthcare Unplugged Conference TranscriptMNTA1:00pm ETTranscriptT1816692Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/bir/1239778bir/1239778normMomenta Pharmaceuticals Inc.United StatesManufacturing: Pharmaceuticals. Services: Research and development.28348731283632541232541454171017CEMNTA3/15/2008 6:17:00 AM1239778Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/T1758483ccbn/T1758483normQ# #### Momenta Earnings Conference Call2/14/2008 4:05:46 PMMomenta106.0000FinalQ4 2007 Momenta Earnings Conference Call TranscriptMNTA10:00am ETTranscriptT1758483Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1752409ccbn/T1752409normMomenta at BIO CEO & Investor Conference2/13/2008 5:06:00 PMMomenta54.0000FinalMomenta at BIO CEO & Investor Conference TranscriptMNTA11:45am ETTranscriptT1752409Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1678590ccbn/T1678590norm11/1/2007 5:08:00 PMMomenta54.0000FinalQ3 2007 Momenta Earnings Conference Call TranscriptMNTA10:00am ET...Good day, everybody, and welcome to today's Momenta Pharmaceuticals Third Quarter #### Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ms. Beverly Holley. Please go ahead. ... TranscriptT1678590Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1602241ccbn/T1602241norm8/7/2007 6:07:00 PMMomenta54.00FinalQ2 2007 Momenta Earnings Conference Call TranscriptMNTA10:00am ET...Good morning, everyone, and welcome to today's Momenta Pharmaceuticals Q# #### earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Rick Shea. Please go ahead, sir. ... TranscriptT1602241Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/-675206668srp/-675206668norm... ##### Incorporated:DelawareWeb Site: www.momentapharma.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs and the discovery of new biological processes. The company is also utilizing its ability to sequence, or analyze the molecular structure of, sugars, to create generic versions of complex sugar-based drugs, or technology-enabled generic products. Through detailed analysis of the molecular structure of complex sugars, the company's technology provides a more complete understanding of the roles that sugars play in cellular function, disease and drug action. Indices:Russell ####, Russell #### IPO Date: ##-##-####... -67520666860877T100MNTA10/6/2006 12:38:00 PM-675206668Credit & Investment ResearchSharkRepellent.net